483
AltaThera Pharmaceuticals LLCAltaThera Pharmaceuticals LLC – FDA 483, Jun 17, 2022
Record Details
Alta'Thera Pharmaceuticals LLC, a corporate headquarters in Chicago, was inspected regarding its postmarketing adverse drug experience processes. The inspection revealed significant deficiencies, including failures to maintain required records for 10 years and incomplete written procedures for adverse event reporting. Additionally, the firm repeatedly failed to submit annual periodic adverse drug experience reports for Sotalol Hydrochloride Injection within the required timeframe.
View Company Profile
ID · 61cf4a9f-8db8-48d3-b91e-6ca77e7d203d
Other documents for AltaThera Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.